New pill hopes to ease breathing in tough lung conditions
Disease control
Recruiting now
This study tests an experimental oral drug, ROC-101, in 40 adults with pulmonary arterial hypertension (PAH) or pulmonary hypertension linked to interstitial lung disease (ILD-PH). Participants take the drug alongside their usual care for 24 weeks, with a long-term follow-up. The…
Phase: PHASE2 • Sponsor: AllRock Bio, Inc. • Aim: Disease control
Last updated May 26, 2026 06:23 UTC